Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on September 16, 2020. The company is an emerging growth company incorporated in Delaware, with principal executive offices in San Francisco, California. The filing primarily serves to disclose a scheduled virtual presentation at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event and does not contain a financial statement or quarterly results.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing references an updated investor presentation (Exhibit 99.1) which may contain such details, but the text of the 8-K itself does not summarize those figures.
Guidance, Outlook, and Risks
The Company's CEO is scheduled to present an updated investor presentation during the conference. The filing explicitly states that the information contained in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities thereof, nor is it incorporated by reference into other filings except as specifically provided.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial data and operational updates referenced in the CEO's presentation.
- Access the recorded webcast at the provided URL (https://jaguarhealth.gcs-web.com/events-and-presentations) for management commentary.
- Verify that the "forward-looking" statements in the presentation are not treated as filed SEC documents for liability purposes.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.